Articles From: CASMED Receives Regulatory Clearance to Market FORE-SIGHT ELITE(R) Oximeters in Japan to Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)


BRANFORD, Conn., June 26, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces receipt of regulatory clearance to market the Company's FORE-SIGHT ELITE® Cerebral Oximeters in Japan.
Sign-up for CASMED Receives Regulatory Clearance to Market FORE-SIGHT ELITE(R) Oximeters in Japan investment picks
BRANFORD, Conn., June 30, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced that on Friday, June 27, 2014, the Company entered into a Loan and Security Agreement (the "Loan Agreement") with General Electric Capital Corporation ("GECC"). Pursuant to the Loan Agreement, GECC is providing the Company with a secured term loan of $7.5 million and a revolving line of credit up to $2.5 million.
Sign-up for CASMED Secures $10 Million Loan Agreement with GE Capital Healthcare Financial Services investment picks
BRANFORD, Conn., July 29, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the second quarter of 2014 on Wednesday, August 6, 2014, prior to the market's opening.
Sign-up for CASMED to Announce Second Quarter 2014 Financial Results and Hold Conference Call on August 6th investment picks
BRANFORD, Conn., Sept.
Sign-up for CASMED to Present at the 5th Annual Craig-Hallum Alpha Select Conference investment picks
Cass Information Systems, Inc. (NASDAQ: CASS), the nation's leading provider of transportation, energy, telecom and environmental invoice payment and information services, reported second quarter 2014 earnings of $.52 per diluted share, the same figure it reported in the second quarter of 2013.
Sign-up for Cass Information Systems, Inc. Reports 2nd Quarter 2014 Earnings investment picks
The Coalition to Abolish Slavery & Trafficking (CAST) , Polaris , and Clear Channel Outdoor (CCO) were joined by county and city elected officials and advocates today as they announced a partnership to raise awareness against human trafficking in the greater Los Angeles area.
Sign-up for CAST, Polaris, & Clear Channel Outdoor Launch Anti-Human Trafficking Awareness Campaign investment picks
2014/8/14
Net Sales Increase 15.0% Driven by Strong Growth of Whiskeys and Gosling's Stormy Ginger Beer NEW YORK , Aug.
Sign-up for Castle Brands Announces Fiscal 2015 First Quarter Results investment picks
FREEPORT, N.Y., June 24, 2014 (GLOBE NEWSWIRE) -- Castle Holding Corp.
Sign-up for Castle Holding Corp. (CHOD: OTC Market) Updates Shareholders investment picks
Today Castlight Health ® , Inc. (NYSE:CSLT) showcased how large companies can reduce wasteful healthcare spending, control costs, and improve employee productivity with the Castlight Enterprise Healthcare Cloud.
Sign-up for Castlight Enterprise Healthcare Cloud Turns Wasted Healthcare Costs Into a Strategic Business Advantage investment picks
Castlight Health ® , Inc. (NYSE:CSLT), a pioneer of the Enterprise Healthcare Cloud, today announced results for its second quarter ended June 30, 2014.
Sign-up for Castlight Health Announces Second Quarter 2014 Results investment picks
2014/7/18
Castlight Health ® , a pioneer in the Enterprise Healthcare Cloud , has further expanded its technology platform through a relationship with Teladoc, the nation’s first and largest telehealth provider with more than 8 million members.
Sign-up for Castlight Health Enters Partnership With Teladoc To Further Expand the Enterprise Healthcare Cloud investment picks
Castlight Health ® , Inc. (NYSE:CSLT), a leading provider of cloud-based enterprise healthcare management software, today announced that it has been selected as one of six companies to showcase its innovative technology as part of the “ Awesome New Technologies for HR ” session at the 17th Annual HR Technology ® Conference and Exposition in Las Vegas.
Sign-up for Castlight Health Selected as an “Awesome New Technology for HR” for 17th Annual HR Technology® Conference and Exposition investment picks
Castlight Health ® , Inc. (NYSE: CSLT), a leading provider of enterprise healthcare cloud software, today announced that Co-Founder and Chief Executive Officer Dr.
Sign-up for Castlight Health to Present at the Canaccord Genuity 34th Annual Growth Conference investment picks
Castlight Health ® , Inc. (NYSE:CSLT), a leading provider of enterprise healthcare cloud software, today announced that Co-Founder and Chief Executive Officer Dr.
Sign-up for Castlight Health to Present at the Morgan Stanley Global Healthcare Conference investment picks
Castlight ® Health, Inc. (NYSE:CSLT), a leading provider of enterprise healthcare cloud software, today announced that it has scheduled a conference call to review its second quarter 2014 results (ended June 30, 2014) for Tuesday, July 29, 2014 at 2:00 pm Pacific Time (5:00 pm Eastern Time). To listen to the conference call live, dial 1-201-689-8562.
Sign-up for Castlight Health, Inc. Conference Call to Review Second Quarter 2014 Results Scheduled for July 29 at 2pm PT investment picks
2014/7/24
NASHVILLE, Tenn.
Sign-up for Cat Financial Announces Second-Quarter 2014 Results investment picks
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has acquired the remaining stake in Redwood Bioscience Inc., and the SMARTag Antibody-Drug Conjugate (ADC) technology platform.
Sign-up for Catalent Expands Its Technology Offerings in Biologics, Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform investment picks
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the fourth quarter and fiscal year ended June 30, 2014.
Sign-up for Catalent Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will release financial results for the fourth quarter and fiscal year ended June 30, 2014 after the market close on Thursday, September 4, 2014.
Sign-up for Catalent, Inc. Announces Fourth Quarter and Fiscal Year 2014 Earnings Conference Webcast investment picks
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products today reaffirms its guidance issued on its earnings call on September 4, 2014 in conjunction with the announcement of the underwriters’ exercise of its option to purchase additional shares in connection with the Initial Public Offering.
Sign-up for Catalent, Inc. Reaffirms Its Guidance Post Underwriters’ Exercise of Its Option to Purchase Additional Shares investment picks
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the Deutsche Bank 2014 Leveraged Finance Conference at 11:25 a.m. MT on Wednesday, October 1, 2014 in Scottsdale, AZ.
Sign-up for Catalent, Inc. to Present at the Deutsche Bank 2014 Leveraged Finance Conference investment picks
Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that John Chiminski, President & Chief Executive Officer, and Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the Morgan Stanley 2014 Global Healthcare Conference at 12:55 p.m. ET on Wednesday, September 10, 2014.
Sign-up for Catalent, Inc. to Present at the Morgan Stanley 2014 Global Healthcare Conference investment picks
2014/10/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0972096001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://media3.marketwire.com/logos/20141007-cata200.jpg TORONTO, ONTARIO --
Sign-up for Catalyst Canada Recognizes BMO CEO Bill Downe for his Extraordinary Leadership in Advancing Women in Business investment picks
Catalyst Paper Corporation Announces Third Quarter 2014 Results Conference Call for Wednesday, November 5, 2014 Canada NewsWire RICHMOND, BC , Oct.
Sign-up for Catalyst Paper Corporation Announces Third Quarter 2014 Results Conference Call for Wednesday, November 5, 2014 investment picks
RICHMOND, BC , July 29, 2014 /PRNewswire/ - Catalyst Paper (TSX:CYT) recorded adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for the second quarter of $7.1 million compared to $25.7 million in the previous quarter.
Sign-up for Catalyst Paper Q2 results impacted by planned maintenance investment picks
CORAL GABLES, Fla., Aug.
Sign-up for Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results investment picks
Brain GABA Levels, a potential surrogate marker of efficacy, will also be followed CORAL GABLES, Fla., Sept.
Sign-up for Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 investment picks
Last Patient Completes 2-Week, Blinded Primary Treatment Period - Top-Line Data on Track to Report in 3Q14 100% of Patients Elected to Continue in 2-Year Open Label Follow-up Period CORAL GABLES, Fla., Aug.
Sign-up for Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CASMED Receives Regulatory Clearance to Market FORE-SIGHT ELITE(R) Oximeters in Japan to Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices